Bayesian Capital Management, LP Arbutus Biopharma Corp Transaction History

Bayesian Capital Management, LP

  • $838 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.98 - $3.17 $23,958 - $38,357
-12,100 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$2.42 - $3.98 $29,282 - $48,158
12,100 New
12,100 $36,000
Q4 2020

Feb 12, 2021
SELL
$2.76 - $4.97 $56,855 - $102,382
-20,600 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$1.75 - $6.2 $36,050 - $127,720
20,600 New
20,600 $64,000

Others Institutions Holding ABUS

# of Institutions
155
Shares Held
99.5M
Call Options Held
2.31M
Put Options Held
525K
View Full List

About Arbutus Biopharma Corp

ABUS Quotes by TradingView
  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $481M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email